Lopp

Lopp v. GlaxoSmithKline, LLC

Good Law
United States District Court, Northern District of CaliforniaOctober 17, 20243:24-cv-06961California420 words

Opinion

Trial Court Opinion

Case 9:20-md-02924-RLR Document 7353 Entered on FLSD Docket 10/17/2024 Page □ □□ □ Case MDL No. 2924 Document 1481 Filed 10/17/ Page 1 of

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: ZANTAC (RANITIDINE) PRODUCTS

LIABILITY LITIGATION MDL No. 2924

eed j (SEE ATTACHED SCHEDULE) come t a eto file ey □□ a te 2; y___v. Adams Oct 17. 3024 CONDITIONAL TRANSFER ORDER (CTO -128)

On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 437 F.Supp.3d 1368 (J.P.M.L. 2020). Since that time, 444 additional action(s) have been transferred to the Southern District of Florida. With the consent of that court, all such actions have been assigned to the Honorable Robin L. Rosenberg. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Florida and assigned to Judge Rosenberg. Pursuant to Rule 7.1 of the Rules…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.